Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $11.77 USD
Change Today -0.22 / -1.83%
Volume 299.6K
HWAY On Other Exchanges
As of 5:20 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

healthways inc (HWAY) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/27/15 - $23.30
52 Week Low
07/7/15 - $11.37
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for HEALTHWAYS INC (HWAY)

healthways inc (HWAY) Related Bloomberg News

View More Bloomberg News

healthways inc (HWAY) Related Businessweek News

View More BusinessWeek News

healthways inc (HWAY) Details

Healthways, Inc., together with its subsidiaries, provides population health management solutions to help people to enhance well-being and health. The company provides personalized solutions for individuals, irrespective of their health status, age, or paying sponsor. Its services are offered through various methods, including venue-based face-to-face interactions; print; phone; mobile and remote devices with applications; on-line, such as social networks; and other combination to motivate and sustain healthy behaviors. The company also provides fostering well-being improvement and disease prevention through biometric screening and proprietary assessments; well-being improvement programs, such as fitness, weight management, stress management, and financial and lifestyle management; and access to its fitness center, physical and occupational therapy, chiropractic, and complementary and alternative medicine provider networks. In addition, it promotes personal change and improvement in the lifestyle behaviors; and offers educational materials to create and sustain healthier behaviors for individuals in the early stages of chronic conditions, as well as personal interactions with healthcare professionals. Further, the company provides evidence-based clinical guidelines into interventions to optimize patient health outcomes; local market resources to address acute episodic interventions; software technology solutions and management consulting in support of well-being improvement services; and high-risk care management services for members at risk for hospitalization due to complex conditions, as well as develops care support plans and coordinates members’ care. It serves health plans, integrated healthcare systems, self-insured employers, hospitals, physician groups, and government entities in North America, Brazil, Australia, and France. The company was founded in 1981 and is headquartered in Franklin, Tennessee.

2,700 Employees
Last Reported Date: 03/13/15
Founded in 1981

healthways inc (HWAY) Top Compensated Officers

Interim Chief Executive Officer, Chief Financ...
Total Annual Compensation: $398.7K
Chief Commercial Officer and President of Nor...
Total Annual Compensation: $700.0K
President of Healthways International
Total Annual Compensation: $419.4K
Senior Vice President and General Counsel
Total Annual Compensation: $277.8K
Chief Accounting Officer, Senior Vice Preside...
Total Annual Compensation: $256.5K
Compensation as of Fiscal Year 2014.

healthways inc (HWAY) Key Developments

Healthways, Inc. Terminates Employment of Matthew Michela as Executive Vice President, Chief Operating Officer

On August 14, 2015, Matthew Michela's employment as Executive Vice President, Chief Operating Officer of Healthways Inc. was terminated, effective immediately.

Healthways Inc. Announces Executive Changes

Healthways Inc. announced that its Board of Directors has appointed Board Chairman, Donato J. Tramuto, as President and Chief Executive Officer effective November 1, 2015. Alfred Lumsdaine, Executive Vice President & Chief Financial Officer, who has been interim CEO since May 2015, will continue to serve as EVP and CFO. Current Director Kevin G. Wills has been elected to serve as the company’s independent Chairman of the Board upon the commencement of Mr. Tramuto’s role as President and CEO. With nearly 35 years of experience at global healthcare companies such as Caremark and i3, at Protocare as a co-founder, and most recently at Physicians Interactive Holdings, a company he founded in 2008 and over which he successfully oversaw expansive growth, Mr. Tramuto is a deeply experienced leader in healthcare. He has been a valued Healthways director for more than two years, including serving as Chairman since 2014. As the President and CEO, he will also continue to serve as a director. Since 2008, Donato J. Tramuto has served as founder, CEO and Chairman of Physicians Interactive Holdings. Kevin G. Wills is a Managing Director, member of the Executive Team, and Chief Financial Officer of AlixPartners. Prior to joining AlixPartners in 2014, Mr. Wills was Executive Vice President and CFO at Saks Inc. Forward Looking Statements This press release contains forward-looking statements, which are based upon current expectations, involve a number of risks and uncertainties and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Those forward-looking statements include all statements that are not historical statements of fact and those regarding the intent, belief or expectations of the Company, including, without limitation, all statements regarding the Board of Directors’ search for a replacement chief executive officer and pursuit of its strategic plan. Those forward-looking statements are subject to certain risks and uncertainties, including, but not limited to those risks detailed in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2014, and other filings with the Securities and Exchange Commission. The Company undertakes no obligation to update or revise any such forward-looking statements.

Healthways Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Revises Earnings Guidance for the Year Ending December 31, 2015

Healthways Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported revenues of $198,073,000 against $180,613,000 a year ago. Operating income was $5,178,000 against $3,702,000 a year ago. Income before income taxes was $617,000 against loss before income taxes of $814,000 a year ago. Net income attributable to the company was $420,000 or $0.01 per basic and diluted share against net loss attributable to the company of $517,000 or $0.01 per basic and diluted share a year ago. Net cash flow from operations for the second quarter of 2015 was $27.2 million. Adjusted net income was $4,189,000 or $0.11 per diluted share against $494,000 or $0.01 per diluted share a year ago. Adjusted EBITDA was $21,862,000 against $17,238,000 a year ago. Capital expenditures were $8.7 million, down 16.2% from the second quarter last year. Adjusted net cash flows provided by operating activities were $28.4 million. For the six months, the company reported revenues of $387,935,000 against $357,391,000 a year ago. Operating income was $4,962,000 against operating loss of $6,799,000 a year ago. Loss before income taxes was $4,090,000 against $15,698,000 a year ago. Net loss attributable to the company was $2,493,000 or $0.07 per basic and diluted share against $10,113,000 or $0.29 per basic and diluted share a year ago. Net cash flows provided by operating activities were $28,987,000 against $19,311,000 a year ago. Acquisition of property and equipment was $17,332,000 against $20,976,000 a year ago. Adjusted net income was $2,320,000 or $0.06 per diluted share against adjusted net loss of $2,079,000 or $0.06 per diluted share a year ago. Adjusted net cash flows provided by operating activities were $43.0 million. The company revised earnings guidance for the full year ending December 31, 2015. For the period, the company’s revenues are expected to be in a range of $770 million to $785 million. Adjusted net income per share is expected to be in a range of $0.07 to $0.15 against prior guidance of $0.35 to 0.47 per share. Loss per share on GAAP basis is expected to be in a range of $0.13 to $0.05 against prior guidance of $0.23 to $0.35. The company expects adjusted operating cash flow for 2015 in a range of $65 million to $75 million, compared with prior guidance in a range of $80 million to $90 million. The company continues to expect total capital expenditures in a range of $37 million to $42 million for 2015. The company expects net cash flows provided by operating activities, GAAP basis to be in the range of $51.0 million to $61.0 million.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HWAY:US $11.77 USD -0.22

HWAY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioScrip Inc $2.40 USD -0.05
Civitas Solutions Inc $24.12 USD +0.06
Five Star Quality Care Inc $3.19 USD -0.04
National HealthCare Corp $59.63 USD +0.33
Providence Service Corp/The $47.19 USD +2.67
View Industry Companies

Industry Analysis


Industry Average

Valuation HWAY Industry Range
Price/Earnings 100.0x
Price/Sales 0.6x
Price/Book 1.4x
Price/Cash Flow 8.0x
TEV/Sales 0.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEALTHWAYS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at